07:00 , Jul 12, 2010 |  BC Week In Review  |  Company News

Biocompatibles, BioCure deal

Biocompatibles acquired BioCure's patents related to Biocompatibles' portfolio of Bead Products for $4.5 million in cash. Biocompatibles licensed the IP from Biocure under a 2002 deal. The acquisition terminates Biocompatibles' obligation to pay a 5%...
07:00 , Apr 28, 2008 |  BC Week In Review  |  Company News

BioCure Inc., ImmuneRegen deal

The companies partnered to develop a wound treatment using ImmuneRegen's Homspera and BioCure's GelSpray Liquid Bandage. Homspera is an analog of the naturally occurring immunomodulator substance P that is in preclinical testing for wound healing....
08:00 , Dec 12, 1994 |  BC Week In Review  |  Company News

Interneuron deal

IPIC's Transcell Technologies Inc. subsidiary and Biocure Ltd. (Aberdeen, Scotland) will develop oligosaccharides to treat cancer. Transcell will use its carbohydrate chemistry to synthesize more potent analogs of Biocure's lead drug candidate, MT2, a small...